This is not the most recent version of the article. View current version (6 JAN 2015)

Intervention Protocol

You have free access to this content

Recurrence after treatment (LLETZ) for cervical intraepithelial neoplasia (CIN): impact of human papillomavirus (HPV) test

  1. Esther van der Heijden1,
  2. Alberto D Lopes2,
  3. Andrew Bryant3,
  4. Ruud Bekkers1,
  5. Khadra Galaal2,*,
  6. Nagindra Das2

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 3 OCT 2013

DOI: 10.1002/14651858.CD010757

How to Cite

van der Heijden E, Lopes AD, Bryant A, Bekkers R, Galaal K, Das N. Recurrence after treatment (LLETZ) for cervical intraepithelial neoplasia (CIN): impact of human papillomavirus (HPV) test (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010757. DOI: 10.1002/14651858.CD010757.

Author Information

  1. 1

    Radboud University Nijmegen Medical Centre, Department of Gynaecology and Obstetrics, Nijmegen, Netherlands

  2. 2

    Princess Alexandra Wing, Royal Cornwall Hospital, Gynaecological Oncology, Truro, Cornwall, UK

  3. 3

    Newcastle University, Institute of Health & Society, Newcastle upon Tyne, UK

*Khadra Galaal, Gynaecological Oncology, Princess Alexandra Wing, Royal Cornwall Hospital, Treliske, Truro, Cornwall, TR1 3LJ, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 3 OCT 2013


This is not the most recent version of the article. View current version (06 JAN 2015)


Additional references

Alvarez 1994
  • Alvarez RD, Helm CW, Edwards RP, et al. Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasia. Gynecologic Oncology 1994;52:175–9.
Bollen 1999
  • Bollen LJ, Tjong-A-Hung SP, van der Velden J, Mol BW, ten Kate FW, ter Schegget J, Bleker OP. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecologic Oncology 1999;72(2):199-201.
Brisson 1994
  • Brisson J, Morin C, Fortier M, et al. Risk factors for cervical intraepithelial neoplasia: differences between low- and high-grade lesions. American Journal of Epidemiology 1994;140(8):700-10.
Brockmeyer AD 2003
  • Brockmeyer AD, Wright JD, Gao F, Powell MA. Persistent and recurrent cervical dysplasia after loop electrosurgical excision procedure. American Journal of Obstetrics and Gynecology 2005;192:1379–81.
Costa 2003
  • Costa S, De Simone P, Venturoli S, et al. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecologic Oncology 2003;90:358–65.
Deeks 2001
  • Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.
DerSimonian 1986
  • Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. and the EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Annals of Oncology 2003;14 Suppl 5:v61-v118.
Fallani 2008
  • Fallani MG, Penna C, Marchionni M, Bussani C, Pieralli A, Andersson KL, Fambrini M. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study. European Journal of Gynaecological Oncology 2008;29(4):378-82.
Galaal 2011
Ghaem-Maghami 2007
  • Ghaem-Maghami S, Sagi S, Majeed G, Soutter WP. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis. Lancet Oncology 2007;8:985-93.
  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer. Lyon, France, 2010; Vol.
Higgins 2003
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. The Cochrane Collaboration 2011; Vol. Available from
Houfflin Debarge 2003
  • Houfflin Debarge V, Collinet P, Vinatier D, et al. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions. Gynecologic Oncology 2003;90:587-92.
Jain 2001
McCredie 2008
  • McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia3: a retrospective cohort study. Lancet Oncology 2008;9:425-34.
Mitchell 1998
  • Mitchell MF, Tortolero-Luna G, Cook E, Whittaker L, Rhodes-Morris H, Silva E. A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstetrics and Gynecology 1998;92:737-44.
Nam 2009
Paraskevaidis E 2000
  • Paraskevaidis E, Lolis ED, Koliopoulos G, Alamanos Y, Fotiou S, Kitchener HC. Cervical intraepithelial neoplasia outcomes after large loop excision with clear margins. Obstetrics and Gynecology 2000;95:828-31.
Parmar 1998
Pinto 2000
Sarian 2004
  • Sarian LO, Derchain SF, Pitta Dda R, Morais SS, Rabelo-Santos SH. Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ). Journal of Clinical Virology 2004;31(4):270-4.
Schiffman 1993
  • Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. Journal of the National Cancer Institute 1993;85(12):958-64.
Soutter 1997
  • Soutter WP, de Barros Lopes A, Fletcher A, Monaghan JM, Duncan ID, Paraskevaidis E, et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997;349:978-80.